Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 249

1.

Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract Collaboration.

Fradet V, Mauermann J, Kassouf W, Rendon R, Jacobsen N, Fairey A, Izawa J, Kapoor A, Black P, Tanguay S, Chin J, So A, Lattouf JB, Bell D, Saad F, Sheyegan B, Drachenberg D, Cagiannos I, Lacombe L.

Urol Oncol. 2014 Aug;32(6):839-45. doi: 10.1016/j.urolonc.2014.04.006.

PMID:
24856978
2.

The characteristics of recurrent upper tract urothelial carcinoma after radical nephroureterectomy without bladder cuff excision.

Kang M, Jeong CW, Kwak C, Kim HH, Ku JH.

Yonsei Med J. 2015 Mar;56(2):375-81. doi: 10.3349/ymj.2015.56.2.375.

3.

Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma.

Milojevic B, Djokic M, Sipetic-Grujicic S, Grozdic Milojevic I, Vuksanovic A, Nikic P, Vukovic I, Djordjevic D, Bumbasirevic U, Tulic C.

Urol Oncol. 2013 Nov;31(8):1615-20. doi: 10.1016/j.urolonc.2012.03.004.

PMID:
22521771
4.

Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.

Cha EK, Shariat SF, Kormaksson M, Novara G, Chromecki TF, Scherr DS, Lotan Y, Raman JD, Kassouf W, Zigeuner R, Remzi M, Bensalah K, Weizer A, Kikuchi E, Bolenz C, Roscigno M, Koppie TM, Ng CK, Fritsche HM, Matsumoto K, Walton TJ, Ehdaie B, Tritschler S, Fajkovic H, Martínez-Salamanca JI, Pycha A, Langner C, Ficarra V, Patard JJ, Montorsi F, Wood CG, Karakiewicz PI, Margulis V.

Eur Urol. 2012 Apr;61(4):818-25. doi: 10.1016/j.eururo.2012.01.021.

PMID:
22284969
5.

Effect of tumor size on recurrence-free survival of upper tract urothelial carcinoma following surgical resection.

Espiritu PN, Sverrisson EF, Sexton WJ, Pow-Sang JM, Poch MA, Dhillon J, Spiess PE.

Urol Oncol. 2014 Jul;32(5):619-24. doi: 10.1016/j.urolonc.2013.11.006.

PMID:
24495448
6.

Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma.

Pignot G, Colin P, Zerbib M, Audenet F, Soulié M, Hurel S, Delage F, Irani J, Descazeaud A, Droupy S, Rozet F, Phé V, Ruffion A, Long JA, Crouzet S, Houlgatte A, Bigot P, Guy L, Faïs PO, Rouprêt M; French Collaborative National Database on UUT-UC..

Urol Oncol. 2014 Jan;32(1):23.e1-8. doi: 10.1016/j.urolonc.2012.08.010.

PMID:
23403206
7.

A Systematic Review and Meta-analysis of Clinicopathologic Factors Linked to Intravesical Recurrence After Radical Nephroureterectomy to Treat Upper Tract Urothelial Carcinoma.

Seisen T, Granger B, Colin P, Léon P, Utard G, Renard-Penna R, Compérat E, Mozer P, Cussenot O, Shariat SF, Rouprêt M.

Eur Urol. 2015 Jun;67(6):1122-33. doi: 10.1016/j.eururo.2014.11.035. Review.

PMID:
25488681
8.

Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.

Yafi FA, Novara G, Shariat SF, Gupta A, Matsumoto K, Walton TJ, Fritsche HM, El-Hakim A, Trischler S, Martínez-Salamanca JI, Seitz C, Ficarra V, Zattoni F, Karakiewicz PI, Kassouf W.

BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x.

9.

Predictors of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: an inflammation-based prognostic score.

Cho YH, Seo YH, Chung SJ, Hwang I, Yu HS, Kim SO, Jung SI, Kang TW, Kwon DD, Park K, Hwang JE, Heo SH, Kim GS, Hwang EC.

Korean J Urol. 2014 Jul;55(7):453-9. doi: 10.4111/kju.2014.55.7.453.

10.
11.

Muscle-invasive bladder cancer developing after nephroureterectomy for upper urinary tract urothelial carcinoma.

Kim KH, You D, Jeong IG, Hong JH, Ahn H, Kim CS.

Urol Oncol. 2013 Nov;31(8):1643-9. doi: 10.1016/j.urolonc.2012.04.014.

PMID:
22591745
12.

Impact of distal ureter management on oncologic outcomes following radical nephroureterectomy for upper tract urothelial carcinoma.

Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, Matsumoto K, Zigeuner R, Pycha A, Scherr DS, Seitz C, Walton T, Trinh QD, Karakiewicz PI, Matin S, Montorsi F, Zerbib M, Shariat SF; Upper Tract Urothelial Carcinoma Collaboration..

Eur Urol. 2014 Jan;65(1):210-7. doi: 10.1016/j.eururo.2012.04.052.

PMID:
22579047
13.

Oncological impact of endoscopic bladder cuff management during nephroureterectomy varies according to upper urinary tract tumor location.

Luo HL, Kang CH, Chen YT, Chuang YC, Cheng YT, Lee WC, Chiang PH.

Int J Urol. 2014 Apr;21(4):366-9. doi: 10.1111/iju.12285.

14.
15.

Surgical management of the distal ureter during radical nephroureterectomy is an independent predictor of oncological outcomes: results of a current series and a review of the literature.

Krabbe LM, Westerman ME, Bagrodia A, Gayed BA, Khalil D, Kapur P, Shariat SF, Raj GV, Sagalowsky AI, Cadeddu JA, Lotan Y, Margulis V.

Urol Oncol. 2014 Jan;32(1):54.e19-26. doi: 10.1016/j.urolonc.2013.08.032.

PMID:
24360665
16.

Independent prognostic factors for initial intravesical recurrence after laparoscopic nephroureterectomy for upper urinary tract urothelial carcinoma.

Liu Y, Lu J, Hong K, Huang Y, Ma L.

Urol Oncol. 2014 Feb;32(2):146-52. doi: 10.1016/j.urolonc.2013.02.018.

PMID:
23628312
17.

The predictive value of positive urine cytology for outcomes following radical nephroureterectomy in patients with primary upper tract urothelial carcinoma: a multi-institutional study.

Tanaka N, Kikuchi E, Kanao K, Matsumoto K, Shirotake S, Kobayashi H, Miyazaki Y, Ide H, Obata J, Hoshino K, Hayakawa N, Kosaka T, Oyama M, Miyajima A, Momma T, Nakagawa K, Jinzaki M, Nakajima Y, Oya M.

Urol Oncol. 2014 Jan;32(1):48.e19-26. doi: 10.1016/j.urolonc.2013.07.003.

PMID:
24055429
18.

Prognostic factors for upper urinary tract urothelial carcinoma after nephroureterectomy.

Kuroda K, Asakuma J, Horiguchi A, Tasaki S, Yoshii H, Sato A, Ito K, Seguchi K, Sumitomo M, Asano T.

Urol Int. 2012;88(2):225-31. doi: 10.1159/000335274.

PMID:
22236640
19.

Preoperative positive urine cytology is a risk factor for subsequent development of bladder cancer after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.

Kobayashi Y, Saika T, Miyaji Y, Saegusa M, Arata R, Akebi N, Takenaka T, Manabe D, Nasu Y, Kumon H.

World J Urol. 2012 Apr;30(2):271-5. doi: 10.1007/s00345-011-0731-y.

PMID:
21805177
20.

Tumour multifocality and grade predict intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma without a history of bladder cancer.

Narukawa T, Hara T, Arai E, Komiyama M, Kawahara T, Kanai Y, Fujimoto H.

Jpn J Clin Oncol. 2015 May;45(5):488-93. doi: 10.1093/jjco/hyv019.

Items per page

Supplemental Content

Support Center